More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a buildup of fat in the liver. This condition can lead ...
A new type of tissue model that more accurately mimics the architecture of the liver could help develop drugs to treat MASLD.